相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells
Husnain Kh Haider et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice
Jenni Huusko et al.
CARDIOVASCULAR RESEARCH (2010)
Sonic Hedgehog Gene Delivery to the Rodent Heart Promotes Angiogenesis via iNOS/Netrin-1/PKC Pathway
Rafeeq P. H. Ahmed et al.
PLOS ONE (2010)
Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury
Nauman Ahmad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction
Longhu Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice
Peter Pokreisz et al.
CIRCULATION (2009)
Phosphodiesterase-5 Inhibitor, Tadalafil, Protects Against Myocardial Ischemia/Reperfusion Through Protein-Kinase G-Dependent Generation of Hydrogen Sulfide
Fadi N. Salloum et al.
CIRCULATION (2009)
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice
Fadi N. Salloum et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes
Manling Zhang et al.
CELLULAR SIGNALLING (2008)
Short hairpin RNA interference therapy for ischemic heart disease
Mei Huang et al.
CIRCULATION (2008)
Phosphodiesterase type 5 - Expanding roles in cardiovascular regulation
David A. Kass et al.
CIRCULATION RESEARCH (2007)
Phosphodiesterase regulation of nitric oxide signaling
David A. Kass et al.
CARDIOVASCULAR RESEARCH (2007)
Overview of PDEs and their regulation
Kenji Omori et al.
CIRCULATION RESEARCH (2007)
Cardiovascular cGMP-generating systems in physiological and pathological conditions
M. C. Cerra et al.
CURRENT MEDICINAL CHEMISTRY (2007)
cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes
Beate Fiedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Navigating the crossroads of coronary artery disease and heart failure
Mihai Gheorghiade et al.
CIRCULATION (2006)
Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling
Ryota Uemura et al.
CIRCULATION RESEARCH (2006)
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al.
NATURE (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Phosphodiesterase type 5 and high altitude pulmonary hypertension
AA Aldashev et al.
THORAX (2005)
Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis
A Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo
D Gou et al.
NUCLEIC ACIDS RESEARCH (2004)
Long-term trends in the incidence of and survival with heart failure
D Levy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Myocardial regeneration therapy for heart failure - Hepatocyte growth factor enhances the effect of cellular cardiomyoplasty
S Miyagawa et al.
CIRCULATION (2002)
Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases
J Tremblay et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Cardiac phosphodiesterase 5 (cGMP-specific) modulates β-adrenergic signaling in vivo and is down-regulated in heart failure
H Senzaki et al.
FASEB JOURNAL (2001)
分享论文
